Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study Investigating the Role of Routine Screening and Molecular Characterisation of Brain Metastasis in the Management of High-risk Metastatic Breast Cancer

NCT06728150 is registered in ClinicalTrials.gov with Monash University as lead sponsor.

NCT NCT06728150
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06728150 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study Investigating the Role of Routine Screening and Molecular Characterisation of Brain Metastasis in the Management of High-risk Metastatic Breast Cancer
Lead sponsor
Monash University
Phase
Observational
Overall status
Not yet recruiting
Start date
December 1, 2024
Completion date
December 31, 2029
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastasases, breast cancer metastatic